Alpha-1-antitrypsin expression in the lung is increased by airway delivery of gene-transfected macrophages

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Gene Therapy

• Publication date

  2003-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/sj.gt.3302121PMID 14625570
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Evaluation of danazol therapy for patients with PiZZ alpha-1-antitrypsin deficiency.

  2015cited by this paper
• Gene Therapy Progress and Prospects: Alpha-1 antitrypsin

  2003cited by this paper
• Morphologic Detection and Functional Assessment of Reconstituted Normal Alveolar Macrophages in the Lungs of SCID Mice1

  2002cited by this paper
• Cell-specific involvement of HNF-1β in α1-antitrypsin gene expression in human respiratory epithelial cells

  2002cited by this paper
• Cell-specific involvement of HNF-1beta in alpha(1)-antitrypsin gene expression in human respiratory epithelial cells.

  2002cited by this paper
• Alpha1-antitrypsin deficiency--a model for conformational diseases.

  2002cited by this paper
• Stable therapeutic serum levels of human alpha-1 antitrypsin (AAT) after portal vein injection of recombinant adeno-associated virus (rAAV) vectors

  2001cited by this paper
• α1-Antitrypsin Deficiency: Biological Answers to Clinical Questions

  2001cited by this paper
• Increased persistence of lung gene expression using plasmids containing the ubiquitin C or elongation factor1α promoter

  2001cited by this paper
• Inhalation of [123I]alpha1-protease inhibitor: toward a new therapeutic concept of alpha1-protease inhibitor deficiency?

  2001cited by this paper
• Longitudinal Follow-up of Patients With α1-Protease Inhibitor Deficiency Before and During Therapy With IV α1-Protease Inhibitor

  2001cited by this paper
• Genetically engineered macrophages expressing IFN-γ restore alveolar immune function in scid mice

  2001cited by this paper
• The Direct Medical Costs of α1-Antitrypsin Deficiency*

  2001cited by this paper
• The direct medical costs of alpha(1)-antitrypsin deficiency.

  2001cited by this paper
• Longitudinal follow-up of patients with alpha(1)-protease inhibitor deficiency before and during therapy with IV alpha(1)-protease inhibitor.

  2001cited by this paper
• Asialofetuin liposome-mediated human α1-antitrypsin gene transfer in vivo results in stationary long-term gene expression

  2001cited by this paper
• Gene therapy in cystic fibrosis.

  2001cited by this paper
• Alpha1-antitrypsin deficiency: biological answers to clinical questions.

  2001cited by this paper
• Pulmonary epithelial expression of human alpha1-antitrypsin in transgenic mice results in delivery of alpha1-antitrypsin protein to the interstitium.

  1999cited by this paper
• Gene therapy for cystic fibrosis.

  1999cited by this paper
• Pulmonary epithelial expression of human α1-antitrypsin in transgenic mice results in delivery of α1-antitrypsin protein to the interstitium

  1999cited by this paper
• A helper virus-free packaging system for recombinant adeno-associated virus vectors.

  1999cited by this paper
• High Doses of a Helper-Dependent Adenoviral Vector Yield Supraphysiological Levels of α 1-Antitrypsin with Negligible Toxicity

  1998cited by this paper
• Transduction of Dendritic Cells by DNA Viral Vectors Directs the Immune Response to Transgene Products in Muscle Fibers

  1998cited by this paper
• Sustained secretion of human alpha-1-antitrypsin from murine muscle transduced with adeno-associated virus vectors.

  1998cited by this paper
• Adeno-Associated Virus as a Vector for Liver-Directed Gene Therapy

  1998cited by this paper
• Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity

  1998cited by this paper
• High doses of a helper-dependent adenoviral vector yield supraphysiological levels of alpha1-antitrypsin with negligible toxicity.

  1998cited by this paper
• Long-term augmentation therapy in twenty patients with severe alpha-1-antitrypsin deficiency--three-year follow-up.

  1997cited by this paper
• Biosynthesis of alpha1-proteinase inhibitor by human lung-derived epithelial cells.

  1997cited by this paper
• Biosynthesis of α1-Proteinase Inhibitor by Human Lung-derived Epithelial Cells*

  1997cited by this paper
• The intrapulmonary half-life and safety of aerosolized alpha1-protease inhibitor in normal volunteers.

  1997cited by this paper
• Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector

  1996cited by this paper
• Characterization of plasmid DNA transfer into mouse skeletal muscle: evaluation of uptake mechanism, expression and secretion of gene products into blood.

  1996cited by this paper
• Long–term hepatic adenovirus–mediated gene expression in mice following CTLA4Ig administration

  1995cited by this paper
• Therapeutic serum concentrations of human alpha‐1‐antitrypsin after adenoviral‐mediated gene transfer into mouse hepatocytes

  1995cited by this paper
• Neutrophil lysosomal dysfunctions in mutant C57 Bl/6J mice: interstrain variations in content of lysosomal elastase, cathepsin G and their inhibitors.

  1994cited by this paper
• Intraperitoneal in vivo gene therapy to deliver alpha 1-antitrypsin to the systemic circulation.

  1994cited by this paper
• Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector.

  1993cited by this paper
• Alpha‐1 antitrypsin response of stimulated alveolar macrophages

  1992cited by this paper
• Adenovirus-mediated transfer of a recombinant alpha 1-antitrypsin gene to the lung epithelium in vivo.

  1991cited by this paper
• Alpha 1-antitrypsin deficiency, emphysema, and liver disease. Genetic basis and strategies for therapy.

  1990cited by this paper
• Replacement therapy for alpha 1-antitrypsin deficiency associated with emphysema.

  1987cited by this paper
• Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution.

  1986cited by this paper
• Danazol-induced augmentation of serum alpha 1-antitrypsin levels in individuals with marked deficiency of this antiprotease.

  1980cited by this paper

• A Unique Amino Acid, Se-Met, Regulates Autophagy and Inflammation in Pseudomonas aeruginosa Infection in Mice through the PAK1/Akt1/mTOR and NF-κB Signaling Pathway.

  2025cites this paper
• Intrapulmonary-administered myeloid derived suppressor cells rescue mice from Pseudomonas aeruginosa infection and promote a regulatory/repair phenotype.

  2025cites this paper
• The Role of Gene Therapy as an Emerging Treatment Strategy for Alpha-1 Antitrypsin Deficiency-Associated Lung Disease: A Systematic Review

  2025cites this paper
• Pseudomonas aeruginosa-infected Myeloid-derived suppressor cells (MDSC) down-regulate lymphocyte activity and improves mice survival, following in vivo lung transfer

  2024cites this paper
• Pulmonary transplantation of alpha-1 antitrypsin (AAT)-transgenic macrophages provides a source of functional human AAT in vivo

  2021cites this paper
• IL-6-elafin genetically modified macrophages as a lung immunotherapeutic strategy against Pseudomonas aeruginosa infections

  2021cites this paper
• Use of IL-6-elafin genetically modified regulatory macrophages as an immunotherapeutic against acute bacterial infection in the lung

  2020cites this paper
• Alpha-1 antitrypsin deficiency and recombinant protein sources with focus on plant sources: updates, challenges and perspectives.

  2020cites this paper
• Future directions: diagnostic approaches and therapy with AAT

  2019cites this paper
• TRPC1 intensifies house dust mite–induced airway remodeling by facilitating epithelial‐to‐mesenchymal transition and STAT3/NF‐κB signaling

  2018cites this paper
• Pseudomonas aeruginosa infection augments inflammation through miR-301b repression of c-Myb-mediated immune activation and infiltration

  2016cites this paper
• Atg7 Knockdown Augments Concanavalin A-Induced Acute Hepatitis through an ROS-Mediated p38/MAPK Pathway

  2016cites this paper
• Identification of proteomic and metabolic signatures associated with chemoresistance of human epithelial ovarian cancer.

  2016cites this paper
• Lyn Delivers Bacteria to Lysosomes for Eradication through TLR2-Initiated Autophagy Related Phagocytosis

  2016influential citation
• Aerosolized Medications for Gene and Peptide Therapy

  2015cites this paper
• A novel chemosynthetic peptide with β-sheet motif efficiently kills Klebsiella pneumoniae in a mouse model

  2015cites this paper
• Atg7 Enhances Host Defense against Infection via Downregulation of Superoxide but Upregulation of Nitric Oxide

  2015cites this paper
• Challenges and Prospects for Alpha-1 Antitrypsin Deficiency Gene Therapy

  2015cites this paper
• Modeling the personalized variations in liver disease due to α1-antitrypsin deficiency using induced pluripotent stem cell-derived hepatocyte-like cells

  2015cites this paper
• FIP200 is Involved in Murine Pseudomonas Infection by Regulating HMGB1 Intracellular Translocation

  2014cites this paper
• High-throughput screening of tumor metastatic-related differential glycoprotein in hepatocellular carcinoma by iTRAQ combines lectin-related techniques

  2013cites this paper
• Nasal and Pulmonary Delivery of Macromolecules to Treat Respiratory and Nonrespiratory Diseases

  2012cites this paper
• Challenges and Opportunities in Gene Delivery

  2011cites this paper
• Diesel exhaust particles are mutagenic in FE1-MutaMouse lung epithelial cells.

  2008cites this paper
• The use of amino acids to enhance the aerosolisation of spray‐dried powders for pulmonary gene therapy

  2005cites this paper
• Pulmonary edema clearance: juicing up the sodium pump.

  2005cites this paper
• Ex Vivo transduced liver progenitor cells as a platform for gene therapy in mice

  2004cites this paper